Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$9,648,215
+$2,140,133 QoQ
Shares Held
8,044
-1.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#1,278
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CONNING INC. holds $254,131,527 across 8 Drug Manufacturers - General names. LLY ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
344,967 | $44,328,259 | |
| 2 | ABBV |
AbbVie Inc.
|
173,581 | $43,679,922 | |
| 3 | JNJ |
Johnson & Johnson
|
156,278 | $39,689,923 | |
| 4 | AMGN |
Amgen Inc
|
108,934 | $39,447,180 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
679,012 | $39,124,671 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
290,397 | $36,688,756 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
8,044 | $9,648,215 | |
| 8 | PFE |
Pfizer Inc
|
63,314 | $1,524,601 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,648,215 | 8,044 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $7,508,082 | 8,163 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $9,397,002 | 8,744 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $7,835,247 | 10,269 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $8,129,718 | 10,429 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $7,760,250 | 9,396 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $8,194,780 | 10,615 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $9,040,131 | 10,204 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $9,573,488 | 10,574 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $8,909,197 | 11,452 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $7,194,398 | 12,342 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $6,674,377 | 12,426 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $6,611,211 | 14,097 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,127,486 | 6,195 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $37,961,387 | 103,765 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $38,088,043 | 117,792 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $47,608,960 | 146,837 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $51,828,101 | 180,983 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $55,321,341 | 200,280 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $46,559,809 | 201,514 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $59,596,933 | 259,659 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $45,137,206 | 241,608 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,977,622 | 11,713 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $1,862,387 | 12,582 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $2,054,220 | 12,512 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,761,327 | 12,697 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||